Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Water metabolism dysregulation refers to abnormalities in the regulation of body water balance, characterized by improper handling of water intake, retention, or loss. This state results from disruptions in hormonal signaling (notably antidiuretic hormone/vasopressin), renal function, or osmotic balance. While not a molecular target itself, this concept underpins a variety of metabolic, renal, and endocrine disorders. Biomarkers such as plasma and serum water T2 assessed by NMR have been proposed for early detection of metabolic dysregulation in clinical settings[1]. The underlying regulators or targets in water metabolism include a range of receptors, channels, and hormones, but “water metabolism dysregulation” is not itself a discrete, actionable target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Water metabolism dysregulation.